Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 8177
TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235724(US9359361, 67 | US10117875, Example 67)
Affinity DataIC50: 25nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235714(US9359361, 54 | US10117875, Example 54)
Affinity DataIC50: 62nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235721(US9359361, 63 | US10117875, Example 63)
Affinity DataIC50: 112nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235716(US9359361, 57 | US10117875, Example 57)
Affinity DataIC50: 113nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235730(US9359361, 73 | US10117875, Example 73)
Affinity DataIC50: 124nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235727(US9359361, 70 | US10117875, Example 70)
Affinity DataIC50: 137nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235732(US9359361, 66 | US10117875, Example 66)
Affinity DataIC50: 181nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235723(US9359361, 65 | US10117875, Example 65)
Affinity DataIC50: 198nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235725(US9359361, 68 | US10117875, Example 68)
Affinity DataIC50: 273nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235713(US9359361, 1 | US10117875, Example 1)
Affinity DataIC50: 285nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235715(US9359361, 56 | US10117875, Example 56)
Affinity DataIC50: 317nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235729(US9359361, 72 | US10117875, Example 72)
Affinity DataIC50: 487nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235731(US9359361, 74 | US10117875, Example 74)
Affinity DataIC50: 901nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235717(US9359361, 59 | US10117875, Example 59)
Affinity DataIC50: 991nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235718(US9359361, 60 | US10117875, Example 60)
Affinity DataIC50: 2.18E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235726(US9359361, 69 | US10117875, Example 69)
Affinity DataIC50: 2.48E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235720(US9359361, 62 | US10117875, Example 62)
Affinity DataIC50: 2.49E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235722(US9359361, 64 | US10117875, Example 64)
Affinity DataIC50: 2.95E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235728(US9359361, 71 | US10117875, Example 71)
Affinity DataIC50: 3.82E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent

TargetToll-like receptor 9(Human)
Janus Biotherapeutics

US Patent
LigandPNGBDBM235719(US9359361, 61 | US10117875, Example 61)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
Go to US Patent